According to SVB Leerink, the prior rating for Bolt Biotherapeutics Inc (NASDAQ:BOLT) was changed from Market Perform to Outperform. In the first quarter, Bolt Biotherapeutics showed an EPS of $0.45, compared to $0.64 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.72 and a 52-week-low of $1.18. Bolt Biotherapeutics closed at $1.60 at the end of the last trading period.

According to Tudor Pickering, the prior rating for Montauk Renewables Inc (NASDAQ:MNTK) was changed from Sell to Hold. For the first quarter, Montauk Renewables had an EPS of $0.03, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $20.78 and a 52-week-low of $5.46. At the end of the last trading period, Montauk Renewables closed at $6.06.

For American States Water Co (NYSE:AWR), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. For the first quarter, American States Water had an EPS of $0.57, compared to year-ago quarter EPS of $0.38. The current stock performance of American States Water shows a 52-week-high of $100.42 and a 52-week-low of $71.23. Moreover, at the end of the last trading period, the closing price was at $89.46.

For Enovis Corp (NYSE:ENOV), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, Enovis showed an EPS of $0.44, compared to $0.37 from the year-ago quarter. The current stock performance of Enovis shows a 52-week-high of $67.66 and a 52-week-low of $44.07. Moreover, at the end of the last trading period, the closing price was at $55.79.

According to Jefferies, the prior rating for Allakos Inc (NASDAQ:ALLK) was changed from Hold to Buy. For the first quarter, Allakos had an EPS of $0.49, compared to year-ago quarter EPS of $3.60. The current stock performance of Allakos shows a 52-week-high of $8.73 and a 52-week-low of $2.54. Moreover, at the end of the last trading period, the closing price was at $4.16.

According to SVB Leerink, the prior rating for Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) was changed from Outperform to Market Perform. For the second quarter, Arrowhead Pharma had an EPS of $0.45, compared to year-ago quarter EPS of $0.41. The current stock performance of Arrowhead Pharma shows a 52-week-high of $48.48 and a 52-week-low of $23.09. Moreover, at the end of the last trading period, the closing price was at $40.08.

For Spirit AeroSystems Holdings Inc (NYSE:SPR), CFRA downgraded the previous rating of Strong Buy to Hold. Spirit AeroSystems Hldgs earned $1.69 in the first quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.55 and a 52-week-low of $21.15. Spirit AeroSystems Hldgs closed at $23.73 at the end of the last trading period.

For Absolute Software Corp (NASDAQ:ABST), Canaccord Genuity downgraded the previous rating of Buy to Hold. In the second quarter, Absolute Software showed an EPS of $0.05, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.57 and a 52-week-low of $6.85. Absolute Software closed at $11.38 at the end of the last trading period.

According to BMO Capital, the prior rating for CTS Corp (NYSE:CTS) was changed from Outperform to Market Perform. For the first quarter, CTS had an EPS of $0.61, compared to year-ago quarter EPS of $0.67. The current stock performance of CTS shows a 52-week-high of $49.59 and a 52-week-low of $31.99. Moreover, at the end of the last trading period, the closing price was at $42.55.

Exane BNP Paribas downgraded the previous rating for PayPal Holdings Inc (NASDAQ:PYPL) from Outperform to Neutral. In the first quarter, PayPal Holdings showed an EPS of $1.17, compared to $0.88 from the year-ago quarter. The stock has a 52-week-high of $103.02 and a 52-week-low of $62.64. At the end of the last trading period, PayPal Holdings closed at $64.18.

Wells Fargo downgraded the previous rating for SJW Group (NYSE:SJW) from Equal-Weight to Underweight. SJW Gr earned $0.37 in the first quarter, compared to $0.09 in the year-ago quarter. The current stock performance of SJW Gr shows a 52-week-high of $83.75 and a 52-week-low of $55.73. Moreover, at the end of the last trading period, the closing price was at $76.18.

According to Wells Fargo, the prior rating for Fox Corp (NASDAQ:FOXA) was changed from Overweight to Equal-Weight. For the third quarter, Fox had an EPS of $0.94, compared to year-ago quarter EPS of $0.81. The current stock performance of Fox shows a 52-week-high of $37.26 and a 52-week-low of $28.02. Moreover, at the end of the last trading period, the closing price was at $30.67.

For ImmunityBio Inc (NASDAQ:IBRX), Piper Sandler downgraded the previous rating of Overweight to Neutral. For the fourth quarter, ImmunityBio had an EPS of $0.27, compared to year-ago quarter EPS of $0.23. The current stock performance of ImmunityBio shows a 52-week-high of $7.80 and a 52-week-low of $1.21. Moreover, at the end of the last trading period, the closing price was at $2.79.

For Aveanna Healthcare Holdings Inc (NASDAQ:AVAH), Raymond James downgraded the previous rating of Strong Buy to Market Perform. In the first quarter, Aveanna Healthcare Hldgs showed an EPS of $0.05, compared to $0.04 from the year-ago quarter. The current stock performance of Aveanna Healthcare Hldgs shows a 52-week-high of $3.15 and a 52-week-low of $0.67. Moreover, at the end of the last trading period, the closing price was at $1.09.

According to Credit Suisse, the prior rating for Home Point Capital Inc (NASDAQ:HMPT) was changed from Outperform to Neutral. Home Point Capital earned $0.20 in the first quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.63 and a 52-week-low of $0.99. Home Point Capital closed at $2.27 at the end of the last trading period.

For Absolute Software Corp (NASDAQ:ABST), Needham downgraded the previous rating of Buy to Hold. For the second quarter, Absolute Software had an EPS of $0.05, compared to year-ago quarter EPS of $0.13. The current stock performance of Absolute Software shows a 52-week-high of $12.57 and a 52-week-low of $6.85. Moreover, at the end of the last trading period, the closing price was at $11.38.

With an Overweight rating, Capital One initiated coverage on Palo Alto Networks Inc (NASDAQ:PANW). The price target seems to have been set at $247.00 for Palo Alto Networks. Palo Alto Networks earned $1.05 in the second quarter, compared to $0.58 in the year-ago quarter. The stock has a 52-week-high of $203.44 and a 52-week-low of $132.22. At the end of the last trading period, Palo Alto Networks closed at $197.18.

Needham initiated coverage on Trinet Group Inc (NYSE:TNET) with a Buy rating. The price target for Trinet Group is set to $115.00. For the first quarter, Trinet Group had an EPS of $2.49, compared to year-ago quarter EPS of $2.55. The stock has a 52-week-high of $95.61 and a 52-week-low of $60.70. At the end of the last trading period, Trinet Group closed at $88.81.

Mizuho initiated coverage on Surgery Partners Inc (NASDAQ:SGRY) with a Buy rating. The price target for Surgery Partners is set to $48.00. Surgery Partners earned $0.08 in the first quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Surgery Partners shows a 52-week-high of $48.47 and a 52-week-low of $20.46. Moreover, at the end of the last trading period, the closing price was at $35.18.

Truist Securities initiated coverage on SoFi Technologies Inc (NASDAQ:SOFI) with a Buy rating. The price target for SoFi Techs is set to $8.00. For the first quarter, SoFi Techs had an EPS of $0.05, compared to year-ago quarter EPS of $0.14. The stock has a 52-week-high of $8.52 and a 52-week-low of $4.25. At the end of the last trading period, SoFi Techs closed at $5.14.

With an Overweight rating, Barclays initiated coverage on Biomea Fusion Inc (NASDAQ:BMEA). The price target seems to have been set at $50.00 for Biomea Fusion. In the first quarter, Biomea Fusion showed an EPS of $0.98, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $36.68 and a 52-week-low of $3.46. Biomea Fusion closed at $32.10 at the end of the last trading period.